• 1
    Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatmentof High Blood Pressure. JAMA. 2003;289:25602572.
  • 2
    Mancia G, De Backer G, Dominiczak A, et al.; 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:14621536.
  • 3
    Tsioufis C, Kasiakogias A, Thomopoulos C, et al. Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy. J Hypertens. 2010;28:875882.
  • 4
    Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement. Circulation. 2008;118:10801111.
  • 5
    Tsioufis C, Thomopoulos C, Stefanadis C. Obstructive sleep apnoea and hypertension: a growing clinical challenge. Hellenic J Cardiol. 2008;49:299302.
  • 6
    Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:13781384.
  • 7
    Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation. 2005;111:614621.
  • 8
    Haentjens P, Meerhaege A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167:757764.
  • 9
    Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50:417423.
  • 10
    Alajmi M, Mulgrew AT, Fox J, et al. Impact of nocturnal nasal continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007;185:6772.
  • 11
    Mo L, He Q. Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnoea hypopnea syndrome: a meta-analysis of clinical trials. Zhonghua Yi Xue Za Zhi. 2007;87:417423.
  • 12
    Barbe’ F, Duran-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;181:718726.
  • 13
    Duran-Cantolla J, Aizpuru F, Montserrat JM, et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomized controlled trial. BMJ. 2010;341:c5991.
  • 14
    Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial. Lancet. 2002;359:204210.
  • 15
    Thomopoulos C, Michalopoulou H, Kasiakogias A, et al. Resistant hypertension and sleep apnea: the sparring partners. Int J Hypertens. 2011;2011:947246.
  • 16
    Pedrosa RP, Drager LF, Gonzaga C, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58:811817.
  • 17
    Tsioufis C, Thomopoulos K, Dimitriadis K, et al. The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J Hypertens. 2007;25:141146.
  • 18
    Tsioufis C, Thomopoulos C, Dimitriadis K, et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis. 2008;52:285293.
  • 19
    Thomopoulos C, Tsioufis C, Dimitriadis K, et al. Obstructive sleep apnea syndrome is associated by enhanced sub-clinical inflammation and asymmetric dimethyl arginine levels in hypertensives. J Hum Hypertens. 2009;23:6567.